Albert Ferro
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Eicosanoids and Hypertension Pharmacology
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Renin-Angiotensin System Studies
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 32
- Blood Pressure and Hypertension Studies 15
- Biochemistry 12
- Eicosanoids and Hypertension Pharmacology 9
- Co-authors
- Christopher N. FloydGabriella PassacqualeYong JiJames M. RitterHaitham H. Al‐Sa'doniLindsay QueenΕugenia GkaliagkousiBiao Xu
- Journals
- British Journal of Clinical Pharmacology (19 papers)British Journal of Pharmacology (10 papers)PLoS ONE (8 papers)Cardiovascular Research (7 papers)Atherosclerosis (5 papers)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Albert Ferro
137 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 150
- Biochemistry 644
- Cardiology and Cardiovascular Medicine 1.7k
- Internal Medicine 203
- Physiology 1.2k
- Clinical Biochemistry 220
Countries citing papers authored by Albert Ferro
This map shows the geographic impact of Albert Ferro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ferro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ferro more than expected).
Fields of papers citing papers by Albert Ferro
This network shows the impact of papers produced by Albert Ferro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ferro. The network helps show where Albert Ferro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Albert Ferro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2016 | 3 | |
| 4 | 2016 | 14 | |
| 5 | 2014 | 4 | |
| 6 | 2014 | 26 | |
| 7 | 2012 | 36 | |
| 8 | 2012 | 31 | |
| 9 | 2010 | 5 | |
| 10 | Pharmaceutical salts: a formulation trick or a clinical conundrum? | 2009 | 13 |
| 11 | 2009 | 61 | |
| 12 | 2009 | 5 | |
| 13 | 2009 | 8 | |
| 14 | Age and gender have important effects on platelet nitric oxide production | 2006 | 3 |
| 15 | Nitric oxide regulates the formation of circulating monocyte-platelet aggregates in healthy subjects | 2006 | 1 |
| 16 | 2006 | 38 | |
| 17 | 2006 | 5 | |
| 18 | 2004 | 7 | |
| 19 | 2003 | 26 | |
| 20 | 1995 | 19 |
About Albert Ferro
Albert Ferro is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry, Physiology, Internal Medicine and Endocrinology, Diabetes and Metabolism, having authored 139 papers that have together received 4.8k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (38 papers), Antiplatelet Therapy and Cardiovascular Diseases (32 papers), Blood Pressure and Hypertension Studies (15 papers), Lipoproteins and Cardiovascular Health (11 papers), Angiogenesis and VEGF in Cancer (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Hormonal Regulation and Hypertension (9 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Biochemistry (644 citations), Cardiology and Cardiovascular Medicine (1.7k citations), Internal Medicine (203 citations), Physiology (1.2k citations) and Clinical Biochemistry (220 citations). Albert Ferro has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include Christopher N. Floyd, Gabriella Passacquale, Yong Ji, James M. Ritter, Haitham H. Al‐Sa'doni, Lindsay Queen, Εugenia Gkaliagkousi, Biao Xu, Pankaj Sharma and Liping Xie. Their work appears in journals such as British Journal of Clinical Pharmacology, British Journal of Pharmacology, PLoS ONE, Cardiovascular Research and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.